23 May 2013
Keywords: wyeth, conbriza, approved, europe, drugmaker, bazedoxifene, been
Article | 28 April 2009
US drugmaker Wyeth's Conbriza (bazedoxifene) has been approved as a treatment of post-menopausal osteoporosis in women at increased risk of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 April 2009
27 April 2009
29 April 2009
© 2013 thepharmaletter.com